Of note, 28% of PET tau-positive cases included in the longitudinal analysis were CSF pTau-negative, revealing that CSF pTau is less accurate than PET tau in predicting cognitive decline in the 38% of cases with low or no cognitive impairment (CN, SMC, EMCI). The gene discussed is MAPT; the disease is Mental deterioration.